FDA gives first ever approval to a drug designed to slow Alzheimer's disease

The Food and Drug Administration on Thursday gave its approval to Leqembi, a drug designed to slow the progression of Alzheimer\'s disease. Leqembi is not considered a cure for Alzheimer’s, but will be covered by Medicare. Dr. Jon LaPook has more. #fda #alzheimers #health \"CBS Evening News with Norah O\'Donnell\" delivers the latest news and original reporting, and goes beyond the headlines with context and depth. Catch the \"CBS Evening News\" weeknights at 6:30 p.m. ET on the CBS Television Network and at 10 p.m. ET on the CBS News app. Subscribe to the \"CBS Evening News\" YouTube channel: https://bit.ly/1S7Dhik Watch full episodes of \"CBS Evening News\": https://cbsn.ws/23XekKA Follow \"CBS Evening News\" on Instagram: https://bit.ly/1T8icTO Like \"CBS Evening News\" on Facebook: https://on.fb.me/1KxYobb Follow \"CBS Evening News\" on Twitter: htt